nodes	percent_of_prediction	percent_of_DWPC	metapath
Tafluprost—PTGS2—type 2 diabetes mellitus	0.659	1	CbGaD
Tafluprost—Common cold—Irbesartan—type 2 diabetes mellitus	0.0064	0.0498	CcSEcCtD
Tafluprost—Iloprost—PLAT—type 2 diabetes mellitus	0.00626	1	CrCbGaD
Tafluprost—Visual acuity reduced—Rosiglitazone—type 2 diabetes mellitus	0.00588	0.0457	CcSEcCtD
Tafluprost—Visual acuity reduced—Pioglitazone—type 2 diabetes mellitus	0.00493	0.0384	CcSEcCtD
Tafluprost—PTGS2—leg—type 2 diabetes mellitus	0.0035	0.198	CbGeAlD
Tafluprost—PTGS2—hindlimb—type 2 diabetes mellitus	0.00313	0.177	CbGeAlD
Tafluprost—Nasopharyngitis—Linagliptin—type 2 diabetes mellitus	0.00297	0.0231	CcSEcCtD
Tafluprost—Urinary tract infection—Linagliptin—type 2 diabetes mellitus	0.00249	0.0193	CcSEcCtD
Tafluprost—Nasopharyngitis—Rosiglitazone—type 2 diabetes mellitus	0.00227	0.0177	CcSEcCtD
Tafluprost—Cataract—Gliclazide—type 2 diabetes mellitus	0.00222	0.0173	CcSEcCtD
Tafluprost—PTGFR—adipose tissue—type 2 diabetes mellitus	0.00214	0.121	CbGeAlD
Tafluprost—Urinary tract infection—Repaglinide—type 2 diabetes mellitus	0.00201	0.0157	CcSEcCtD
Tafluprost—PTGS2—artery—type 2 diabetes mellitus	0.00192	0.108	CbGeAlD
Tafluprost—Rhinitis—Repaglinide—type 2 diabetes mellitus	0.00186	0.0145	CcSEcCtD
Tafluprost—Nasopharyngitis—Sitagliptin—type 2 diabetes mellitus	0.00185	0.0144	CcSEcCtD
Tafluprost—Cough—Linagliptin—type 2 diabetes mellitus	0.00174	0.0136	CcSEcCtD
Tafluprost—Eye disorder—Repaglinide—type 2 diabetes mellitus	0.00174	0.0135	CcSEcCtD
Tafluprost—Nasopharyngitis—Bromocriptine—type 2 diabetes mellitus	0.00167	0.013	CcSEcCtD
Tafluprost—Cataract—Losartan—type 2 diabetes mellitus	0.00165	0.0128	CcSEcCtD
Tafluprost—Eye disorder—Rosiglitazone—type 2 diabetes mellitus	0.00164	0.0128	CcSEcCtD
Tafluprost—Cough—Nateglinide—type 2 diabetes mellitus	0.00163	0.0127	CcSEcCtD
Tafluprost—PTGS2—endothelium—type 2 diabetes mellitus	0.00162	0.0915	CbGeAlD
Tafluprost—Urinary tract infection—Pioglitazone—type 2 diabetes mellitus	0.0016	0.0124	CcSEcCtD
Tafluprost—Urinary tract infection—Sitagliptin—type 2 diabetes mellitus	0.00155	0.012	CcSEcCtD
Tafluprost—Rhinitis—Glipizide—type 2 diabetes mellitus	0.00154	0.012	CcSEcCtD
Tafluprost—PTGFR—liver—type 2 diabetes mellitus	0.0015	0.0848	CbGeAlD
Tafluprost—Eye disorder—Glipizide—type 2 diabetes mellitus	0.00144	0.0112	CcSEcCtD
Tafluprost—Eye disorder—Pioglitazone—type 2 diabetes mellitus	0.00138	0.0107	CcSEcCtD
Tafluprost—Eye disorder—Sitagliptin—type 2 diabetes mellitus	0.00134	0.0104	CcSEcCtD
Tafluprost—Asthma—Gliclazide—type 2 diabetes mellitus	0.00133	0.0103	CcSEcCtD
Tafluprost—Rhinitis—Bromocriptine—type 2 diabetes mellitus	0.0013	0.0101	CcSEcCtD
Tafluprost—Pruritus—Tolbutamide—type 2 diabetes mellitus	0.00128	0.00996	CcSEcCtD
Tafluprost—Vision blurred—Glipizide—type 2 diabetes mellitus	0.00126	0.00981	CcSEcCtD
Tafluprost—Nervous system disorder—Rosiglitazone—type 2 diabetes mellitus	0.00122	0.00952	CcSEcCtD
Tafluprost—Eye disorder—Bromocriptine—type 2 diabetes mellitus	0.00121	0.00941	CcSEcCtD
Tafluprost—Asthma—Orlistat—type 2 diabetes mellitus	0.00121	0.00937	CcSEcCtD
Tafluprost—Vision blurred—Glimepiride—type 2 diabetes mellitus	0.00118	0.00916	CcSEcCtD
Tafluprost—Vision blurred—Sitagliptin—type 2 diabetes mellitus	0.00117	0.00913	CcSEcCtD
Tafluprost—Pruritus—Chlorpropamide—type 2 diabetes mellitus	0.00117	0.00906	CcSEcCtD
Tafluprost—Pruritus—Tolazamide—type 2 diabetes mellitus	0.00117	0.00906	CcSEcCtD
Tafluprost—Urinary tract infection—Gliclazide—type 2 diabetes mellitus	0.00115	0.00895	CcSEcCtD
Tafluprost—Nasopharyngitis—Metformin—type 2 diabetes mellitus	0.00115	0.00894	CcSEcCtD
Tafluprost—Headache—Tolbutamide—type 2 diabetes mellitus	0.00113	0.00882	CcSEcCtD
Tafluprost—Eye disorder—Glyburide—type 2 diabetes mellitus	0.00111	0.0086	CcSEcCtD
Tafluprost—Cough—Sitagliptin—type 2 diabetes mellitus	0.00109	0.00845	CcSEcCtD
Tafluprost—Nasopharyngitis—Irbesartan—type 2 diabetes mellitus	0.00109	0.00843	CcSEcCtD
Tafluprost—Pruritus—Nateglinide—type 2 diabetes mellitus	0.00108	0.00839	CcSEcCtD
Tafluprost—Rhinitis—Gliclazide—type 2 diabetes mellitus	0.00107	0.00829	CcSEcCtD
Tafluprost—Vision blurred—Bromocriptine—type 2 diabetes mellitus	0.00106	0.00826	CcSEcCtD
Tafluprost—Asthma—Irbesartan—type 2 diabetes mellitus	0.00105	0.00815	CcSEcCtD
Tafluprost—Urinary tract infection—Orlistat—type 2 diabetes mellitus	0.00105	0.00812	CcSEcCtD
Tafluprost—Headache—Tolazamide—type 2 diabetes mellitus	0.00103	0.00802	CcSEcCtD
Tafluprost—Headache—Chlorpropamide—type 2 diabetes mellitus	0.00103	0.00802	CcSEcCtD
Tafluprost—Nervous system disorder—Pioglitazone—type 2 diabetes mellitus	0.00103	0.00798	CcSEcCtD
Tafluprost—Headache—Linagliptin—type 2 diabetes mellitus	0.00102	0.00794	CcSEcCtD
Tafluprost—Nervous system disorder—Sitagliptin—type 2 diabetes mellitus	0.000997	0.00775	CcSEcCtD
Tafluprost—Eye disorder—Gliclazide—type 2 diabetes mellitus	0.000994	0.00772	CcSEcCtD
Tafluprost—Rhinitis—Valsartan—type 2 diabetes mellitus	0.000979	0.00761	CcSEcCtD
Tafluprost—Dyspnoea—Glipizide—type 2 diabetes mellitus	0.000975	0.00757	CcSEcCtD
Tafluprost—Vision blurred—Glyburide—type 2 diabetes mellitus	0.000971	0.00755	CcSEcCtD
Tafluprost—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000935	0.00727	CcSEcCtD
Tafluprost—Dyspnoea—Pioglitazone—type 2 diabetes mellitus	0.000934	0.00726	CcSEcCtD
Tafluprost—PTGS2—islet of Langerhans—type 2 diabetes mellitus	0.000922	0.0521	CbGeAlD
Tafluprost—Dyspnoea—Glimepiride—type 2 diabetes mellitus	0.000909	0.00707	CcSEcCtD
Tafluprost—Urinary tract infection—Irbesartan—type 2 diabetes mellitus	0.000909	0.00707	CcSEcCtD
Tafluprost—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.000902	0.00701	CcSEcCtD
Tafluprost—Rhinitis—Metformin—type 2 diabetes mellitus	0.000892	0.00693	CcSEcCtD
Tafluprost—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000883	0.00687	CcSEcCtD
Tafluprost—Urinary tract infection—Losartan—type 2 diabetes mellitus	0.000855	0.00665	CcSEcCtD
Tafluprost—Asthma—Ramipril—type 2 diabetes mellitus	0.000846	0.00658	CcSEcCtD
Tafluprost—Rhinitis—Irbesartan—type 2 diabetes mellitus	0.000842	0.00654	CcSEcCtD
Tafluprost—Eye disorder—Metformin—type 2 diabetes mellitus	0.000831	0.00646	CcSEcCtD
Tafluprost—Headache—Repaglinide—type 2 diabetes mellitus	0.000828	0.00643	CcSEcCtD
Tafluprost—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000825	0.00641	CcSEcCtD
Tafluprost—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.00082	0.00638	CcSEcCtD
Tafluprost—Cough—Gliclazide—type 2 diabetes mellitus	0.000808	0.00628	CcSEcCtD
Tafluprost—Vision blurred—Valsartan—type 2 diabetes mellitus	0.000801	0.00623	CcSEcCtD
Tafluprost—Rhinitis—Losartan—type 2 diabetes mellitus	0.000792	0.00616	CcSEcCtD
Tafluprost—Vision blurred—Orlistat—type 2 diabetes mellitus	0.000792	0.00616	CcSEcCtD
Tafluprost—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000782	0.00608	CcSEcCtD
Tafluprost—Pruritus—Glipizide—type 2 diabetes mellitus	0.000773	0.00601	CcSEcCtD
Tafluprost—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.00075	0.00583	CcSEcCtD
Tafluprost—Cough—Valsartan—type 2 diabetes mellitus	0.000742	0.00577	CcSEcCtD
Tafluprost—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000741	0.00576	CcSEcCtD
Tafluprost—Urinary tract infection—Ramipril—type 2 diabetes mellitus	0.000734	0.0057	CcSEcCtD
Tafluprost—Cough—Orlistat—type 2 diabetes mellitus	0.000733	0.0057	CcSEcCtD
Tafluprost—Vision blurred—Metformin—type 2 diabetes mellitus	0.00073	0.00567	CcSEcCtD
Tafluprost—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000722	0.00561	CcSEcCtD
Tafluprost—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000689	0.00535	CcSEcCtD
Tafluprost—Headache—Glipizide—type 2 diabetes mellitus	0.000685	0.00532	CcSEcCtD
Tafluprost—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000681	0.00529	CcSEcCtD
Tafluprost—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000673	0.00523	CcSEcCtD
Tafluprost—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000673	0.00523	CcSEcCtD
Tafluprost—PTGS2—cardiovascular system—type 2 diabetes mellitus	0.000667	0.0377	CbGeAlD
Tafluprost—Headache—Pioglitazone—type 2 diabetes mellitus	0.000656	0.0051	CcSEcCtD
Tafluprost—PTGS2—kidney—type 2 diabetes mellitus	0.000652	0.0369	CbGeAlD
Tafluprost—Vision blurred—Losartan—type 2 diabetes mellitus	0.000648	0.00504	CcSEcCtD
Tafluprost—PTGS2—pancreas—type 2 diabetes mellitus	0.000648	0.0366	CbGeAlD
Tafluprost—Headache—Glimepiride—type 2 diabetes mellitus	0.000639	0.00497	CcSEcCtD
Tafluprost—Cough—Irbesartan—type 2 diabetes mellitus	0.000638	0.00496	CcSEcCtD
Tafluprost—Headache—Sitagliptin—type 2 diabetes mellitus	0.000637	0.00495	CcSEcCtD
Tafluprost—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.00062	0.00482	CcSEcCtD
Tafluprost—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000619	0.00481	CcSEcCtD
Tafluprost—Cough—Losartan—type 2 diabetes mellitus	0.0006	0.00466	CcSEcCtD
Tafluprost—Pruritus—Glyburide—type 2 diabetes mellitus	0.000595	0.00463	CcSEcCtD
Tafluprost—PTGS2—adipose tissue—type 2 diabetes mellitus	0.000588	0.0332	CbGeAlD
Tafluprost—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000585	0.00455	CcSEcCtD
Tafluprost—Headache—Bromocriptine—type 2 diabetes mellitus	0.000576	0.00448	CcSEcCtD
Tafluprost—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000563	0.00438	CcSEcCtD
Tafluprost—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.00055	0.00428	CcSEcCtD
Tafluprost—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000534	0.00415	CcSEcCtD
Tafluprost—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000532	0.00413	CcSEcCtD
Tafluprost—Headache—Glyburide—type 2 diabetes mellitus	0.000527	0.0041	CcSEcCtD
Tafluprost—Cough—Ramipril—type 2 diabetes mellitus	0.000515	0.004	CcSEcCtD
Tafluprost—Dyspnoea—Losartan—type 2 diabetes mellitus	0.0005	0.00389	CcSEcCtD
Tafluprost—Pruritus—Valsartan—type 2 diabetes mellitus	0.000491	0.00382	CcSEcCtD
Tafluprost—Pruritus—Orlistat—type 2 diabetes mellitus	0.000485	0.00377	CcSEcCtD
Tafluprost—Headache—Gliclazide—type 2 diabetes mellitus	0.000473	0.00368	CcSEcCtD
Tafluprost—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000472	0.00367	CcSEcCtD
Tafluprost—Pruritus—Metformin—type 2 diabetes mellitus	0.000447	0.00348	CcSEcCtD
Tafluprost—Headache—Valsartan—type 2 diabetes mellitus	0.000435	0.00338	CcSEcCtD
Tafluprost—Headache—Orlistat—type 2 diabetes mellitus	0.00043	0.00334	CcSEcCtD
Tafluprost—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000429	0.00334	CcSEcCtD
Tafluprost—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000422	0.00328	CcSEcCtD
Tafluprost—PTGS2—liver—type 2 diabetes mellitus	0.000412	0.0233	CbGeAlD
Tafluprost—Pruritus—Losartan—type 2 diabetes mellitus	0.000397	0.00309	CcSEcCtD
Tafluprost—Headache—Metformin—type 2 diabetes mellitus	0.000396	0.00308	CcSEcCtD
Tafluprost—Headache—Irbesartan—type 2 diabetes mellitus	0.000374	0.0029	CcSEcCtD
Tafluprost—Headache—Losartan—type 2 diabetes mellitus	0.000352	0.00273	CcSEcCtD
Tafluprost—Pruritus—Ramipril—type 2 diabetes mellitus	0.000341	0.00265	CcSEcCtD
Tafluprost—Headache—Ramipril—type 2 diabetes mellitus	0.000302	0.00234	CcSEcCtD
Tafluprost—PTGFR—GPCR downstream signaling—C3—type 2 diabetes mellitus	0.000117	0.000621	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	0.000116	0.000613	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—CASP3—type 2 diabetes mellitus	0.000115	0.000608	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	0.000114	0.000606	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IAPP—type 2 diabetes mellitus	0.000114	0.000602	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—INSR—type 2 diabetes mellitus	0.000113	0.000599	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000111	0.00059	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000111	0.000588	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000111	0.000587	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.00011	0.000585	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000109	0.000577	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—MMP9—type 2 diabetes mellitus	0.000108	0.000575	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PTGDS—type 2 diabetes mellitus	0.000108	0.000573	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—AANAT—type 2 diabetes mellitus	0.000108	0.000573	CbGpPWpGaD
Tafluprost—PTGS2—Disease—SLC5A4—type 2 diabetes mellitus	0.000108	0.000571	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000106	0.000564	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.000106	0.00056	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—TNF—type 2 diabetes mellitus	0.000105	0.000559	CbGpPWpGaD
Tafluprost—PTGS2—Disease—G6PC—type 2 diabetes mellitus	0.000104	0.000552	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PPP1R3C—type 2 diabetes mellitus	0.000104	0.000552	CbGpPWpGaD
Tafluprost—PTGS2—Disease—ENPP1—type 2 diabetes mellitus	0.000104	0.000552	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—type 2 diabetes mellitus	0.000103	0.000547	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.000103	0.000545	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	0.000103	0.000545	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000102	0.000544	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000102	0.000544	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CDO1—type 2 diabetes mellitus	0.000102	0.000543	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GPD2—type 2 diabetes mellitus	0.000102	0.000543	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—type 2 diabetes mellitus	0.000101	0.000537	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.000101	0.000536	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	0.0001	0.000531	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—EDNRA—type 2 diabetes mellitus	9.97e-05	0.000529	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	9.95e-05	0.000528	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CALM1—type 2 diabetes mellitus	9.93e-05	0.000527	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CYBA—type 2 diabetes mellitus	9.93e-05	0.000526	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—AK1—type 2 diabetes mellitus	9.77e-05	0.000518	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	9.76e-05	0.000517	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—GHRL—type 2 diabetes mellitus	9.72e-05	0.000515	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PLAT—type 2 diabetes mellitus	9.72e-05	0.000515	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	9.66e-05	0.000512	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CALCA—type 2 diabetes mellitus	9.6e-05	0.000509	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	9.33e-05	0.000495	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	9.04e-05	0.000479	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—SLC5A4—type 2 diabetes mellitus	9.02e-05	0.000478	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—MAT1A—type 2 diabetes mellitus	9.02e-05	0.000478	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	9e-05	0.000477	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	8.98e-05	0.000476	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—TGFB1—type 2 diabetes mellitus	8.93e-05	0.000474	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—GCG—type 2 diabetes mellitus	8.89e-05	0.000471	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PTPN1—type 2 diabetes mellitus	8.89e-05	0.000471	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	8.85e-05	0.000469	CbGpPWpGaD
Tafluprost—PTGS2—Disease—ACACA—type 2 diabetes mellitus	8.84e-05	0.000469	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	8.82e-05	0.000467	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—EGFR—type 2 diabetes mellitus	8.76e-05	0.000464	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	8.74e-05	0.000464	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	8.74e-05	0.000463	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	8.71e-05	0.000462	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ENPP1—type 2 diabetes mellitus	8.71e-05	0.000462	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—G6PC—type 2 diabetes mellitus	8.71e-05	0.000462	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—HBA2—type 2 diabetes mellitus	8.71e-05	0.000462	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ND1—type 2 diabetes mellitus	8.71e-05	0.000462	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PPP1R3C—type 2 diabetes mellitus	8.71e-05	0.000462	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—IL6—type 2 diabetes mellitus	8.51e-05	0.000451	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GCGR—type 2 diabetes mellitus	8.44e-05	0.000447	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—TNF—type 2 diabetes mellitus	8.34e-05	0.000442	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CCL2—type 2 diabetes mellitus	8.32e-05	0.000441	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—AKT2—type 2 diabetes mellitus	8.17e-05	0.000433	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	8.16e-05	0.000433	CbGpPWpGaD
Tafluprost—PTGS2—Disease—SLC5A2—type 2 diabetes mellitus	8.16e-05	0.000433	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	8.12e-05	0.000431	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CYTB—type 2 diabetes mellitus	7.97e-05	0.000423	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—OXCT1—type 2 diabetes mellitus	7.97e-05	0.000423	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	7.8e-05	0.000414	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—SRD5A1—type 2 diabetes mellitus	7.76e-05	0.000412	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	7.73e-05	0.00041	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—GNB3—type 2 diabetes mellitus	7.66e-05	0.000406	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—AVP—type 2 diabetes mellitus	7.56e-05	0.000401	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MMP3—type 2 diabetes mellitus	7.56e-05	0.000401	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IGF2—type 2 diabetes mellitus	7.52e-05	0.000399	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	7.49e-05	0.000397	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	7.41e-05	0.000393	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PCK1—type 2 diabetes mellitus	7.41e-05	0.000393	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—STAR—type 2 diabetes mellitus	7.41e-05	0.000393	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ACACA—type 2 diabetes mellitus	7.41e-05	0.000393	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—HSD17B3—type 2 diabetes mellitus	7.41e-05	0.000393	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—APOB—type 2 diabetes mellitus	7.3e-05	0.000387	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	7.29e-05	0.000387	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IGF1R—type 2 diabetes mellitus	7.27e-05	0.000386	CbGpPWpGaD
Tafluprost—PTGS2—Disease—TLE4—type 2 diabetes mellitus	7.21e-05	0.000382	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—EDN1—type 2 diabetes mellitus	7.19e-05	0.000381	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ABCC8—type 2 diabetes mellitus	7.1e-05	0.000377	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CBS—type 2 diabetes mellitus	7.1e-05	0.000377	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—LPL—type 2 diabetes mellitus	6.97e-05	0.00037	CbGpPWpGaD
Tafluprost—PTGS2—Disease—HK1—type 2 diabetes mellitus	6.94e-05	0.000368	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—COX2—type 2 diabetes mellitus	6.84e-05	0.000362	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—SLC5A2—type 2 diabetes mellitus	6.84e-05	0.000362	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—ADCY5—type 2 diabetes mellitus	6.83e-05	0.000362	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	6.8e-05	0.00036	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—IL6—type 2 diabetes mellitus	6.73e-05	0.000357	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—NCOA6—type 2 diabetes mellitus	6.72e-05	0.000356	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	6.71e-05	0.000356	CbGpPWpGaD
Tafluprost—PTGS2—Disease—GCKR—type 2 diabetes mellitus	6.7e-05	0.000355	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	6.62e-05	0.000351	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—HSD11B1—type 2 diabetes mellitus	6.6e-05	0.00035	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—UCP2—type 2 diabetes mellitus	6.6e-05	0.00035	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—UCP3—type 2 diabetes mellitus	6.6e-05	0.00035	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6.54e-05	0.000347	CbGpPWpGaD
Tafluprost—PTGS2—Disease—ALDOB—type 2 diabetes mellitus	6.43e-05	0.000341	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CCR5—type 2 diabetes mellitus	6.42e-05	0.000341	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	6.4e-05	0.000339	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—C3—type 2 diabetes mellitus	6.28e-05	0.000333	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PCK1—type 2 diabetes mellitus	6.21e-05	0.000329	CbGpPWpGaD
Tafluprost—PTGS2—Disease—SPRY2—type 2 diabetes mellitus	6.13e-05	0.000325	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	6.11e-05	0.000324	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	6.08e-05	0.000322	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.99e-05	0.000318	CbGpPWpGaD
Tafluprost—PTGS2—Disease—RBP4—type 2 diabetes mellitus	5.97e-05	0.000317	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.97e-05	0.000317	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—AGT—type 2 diabetes mellitus	5.97e-05	0.000316	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	5.96e-05	0.000316	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	5.96e-05	0.000316	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.87e-05	0.000311	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—APOE—type 2 diabetes mellitus	5.84e-05	0.00031	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—LEP—type 2 diabetes mellitus	5.84e-05	0.00031	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—HK1—type 2 diabetes mellitus	5.81e-05	0.000308	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	5.81e-05	0.000308	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.78e-05	0.000306	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	5.67e-05	0.000301	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—KCNJ11—type 2 diabetes mellitus	5.61e-05	0.000298	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—LPA—type 2 diabetes mellitus	5.61e-05	0.000298	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GCKR—type 2 diabetes mellitus	5.61e-05	0.000298	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—HSD3B2—type 2 diabetes mellitus	5.61e-05	0.000298	CbGpPWpGaD
Tafluprost—PTGS2—Disease—SLC2A2—type 2 diabetes mellitus	5.58e-05	0.000296	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.51e-05	0.000292	CbGpPWpGaD
Tafluprost—PTGS2—Disease—MTR—type 2 diabetes mellitus	5.46e-05	0.00029	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	5.4e-05	0.000286	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ALDOB—type 2 diabetes mellitus	5.38e-05	0.000285	CbGpPWpGaD
Tafluprost—PTGS2—Disease—NAMPT—type 2 diabetes mellitus	5.36e-05	0.000284	CbGpPWpGaD
Tafluprost—PTGS2—Disease—GCK—type 2 diabetes mellitus	5.32e-05	0.000282	CbGpPWpGaD
Tafluprost—PTGS2—Disease—IAPP—type 2 diabetes mellitus	5.29e-05	0.000281	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	5.23e-05	0.000277	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.21e-05	0.000277	CbGpPWpGaD
Tafluprost—PTGS2—Disease—SLC9A1—type 2 diabetes mellitus	5.2e-05	0.000276	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	5.12e-05	0.000272	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	5.06e-05	0.000269	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GLP1R—type 2 diabetes mellitus	5e-05	0.000265	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—INS—type 2 diabetes mellitus	4.99e-05	0.000265	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.91e-05	0.000261	CbGpPWpGaD
Tafluprost—PTGS2—Disease—HMGA1—type 2 diabetes mellitus	4.87e-05	0.000258	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.83e-05	0.000256	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.83e-05	0.000256	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.81e-05	0.000255	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PSMD6—type 2 diabetes mellitus	4.78e-05	0.000253	CbGpPWpGaD
Tafluprost—PTGS2—Disease—SNAP25—type 2 diabetes mellitus	4.78e-05	0.000253	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—SLC2A2—type 2 diabetes mellitus	4.67e-05	0.000248	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CYBA—type 2 diabetes mellitus	4.63e-05	0.000245	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.59e-05	0.000243	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CPT1A—type 2 diabetes mellitus	4.58e-05	0.000243	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—MTR—type 2 diabetes mellitus	4.58e-05	0.000243	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—NAMPT—type 2 diabetes mellitus	4.49e-05	0.000238	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CALCA—type 2 diabetes mellitus	4.47e-05	0.000237	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	4.46e-05	0.000237	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—HBA1—type 2 diabetes mellitus	4.46e-05	0.000236	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—LIPC—type 2 diabetes mellitus	4.46e-05	0.000236	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GCK—type 2 diabetes mellitus	4.46e-05	0.000236	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CYP11A1—type 2 diabetes mellitus	4.43e-05	0.000235	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.38e-05	0.000232	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.38e-05	0.000232	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—SLC9A1—type 2 diabetes mellitus	4.35e-05	0.000231	CbGpPWpGaD
Tafluprost—PTGS2—Disease—SLC2A1—type 2 diabetes mellitus	4.32e-05	0.000229	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CETP—type 2 diabetes mellitus	4.3e-05	0.000228	CbGpPWpGaD
Tafluprost—PTGS2—Disease—NOS1—type 2 diabetes mellitus	4.26e-05	0.000226	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	4.22e-05	0.000224	CbGpPWpGaD
Tafluprost—PTGS2—Disease—TCF7L2—type 2 diabetes mellitus	4.21e-05	0.000223	CbGpPWpGaD
Tafluprost—PTGS2—Disease—SLC2A4—type 2 diabetes mellitus	4.14e-05	0.00022	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—RELA—type 2 diabetes mellitus	4.12e-05	0.000219	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	4.01e-05	0.000213	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—SNAP25—type 2 diabetes mellitus	4e-05	0.000212	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—SREBF1—type 2 diabetes mellitus	4e-05	0.000212	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PSMD6—type 2 diabetes mellitus	4e-05	0.000212	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CTGF—type 2 diabetes mellitus	3.93e-05	0.000208	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—HMGCR—type 2 diabetes mellitus	3.89e-05	0.000206	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.84e-05	0.000203	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ADRA2A—type 2 diabetes mellitus	3.81e-05	0.000202	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.75e-05	0.000199	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.72e-05	0.000197	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.69e-05	0.000196	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CYP2E1—type 2 diabetes mellitus	3.66e-05	0.000194	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CYP1A2—type 2 diabetes mellitus	3.62e-05	0.000192	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—SLC2A1—type 2 diabetes mellitus	3.62e-05	0.000192	CbGpPWpGaD
Tafluprost—PTGS2—Disease—TGFBR2—type 2 diabetes mellitus	3.6e-05	0.000191	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CYP3A4—type 2 diabetes mellitus	3.53e-05	0.000187	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.51e-05	0.000186	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CDKN2B—type 2 diabetes mellitus	3.49e-05	0.000185	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.48e-05	0.000184	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—SLC2A4—type 2 diabetes mellitus	3.47e-05	0.000184	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GCG—type 2 diabetes mellitus	3.47e-05	0.000184	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.41e-05	0.000181	CbGpPWpGaD
Tafluprost—PTGS2—Disease—APOB—type 2 diabetes mellitus	3.4e-05	0.00018	CbGpPWpGaD
Tafluprost—PTGS2—Disease—LPL—type 2 diabetes mellitus	3.25e-05	0.000172	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—SRC—type 2 diabetes mellitus	3.24e-05	0.000172	CbGpPWpGaD
Tafluprost—PTGS2—Disease—ADCY5—type 2 diabetes mellitus	3.18e-05	0.000169	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.15e-05	0.000167	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PPP2CA—type 2 diabetes mellitus	3.05e-05	0.000162	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CCR5—type 2 diabetes mellitus	2.99e-05	0.000159	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GNB3—type 2 diabetes mellitus	2.99e-05	0.000159	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.99e-05	0.000159	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—HMOX1—type 2 diabetes mellitus	2.98e-05	0.000158	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CAT—type 2 diabetes mellitus	2.94e-05	0.000156	CbGpPWpGaD
Tafluprost—PTGS2—Disease—MTHFR—type 2 diabetes mellitus	2.93e-05	0.000155	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.9e-05	0.000154	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—APOB—type 2 diabetes mellitus	2.85e-05	0.000151	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.84e-05	0.000151	CbGpPWpGaD
Tafluprost—PTGS2—Disease—HIF1A—type 2 diabetes mellitus	2.79e-05	0.000148	CbGpPWpGaD
Tafluprost—PTGS2—Disease—IRS2—type 2 diabetes mellitus	2.78e-05	0.000148	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GSTM1—type 2 diabetes mellitus	2.77e-05	0.000147	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CALM1—type 2 diabetes mellitus	2.73e-05	0.000145	CbGpPWpGaD
Tafluprost—PTGS2—Disease—APOE—type 2 diabetes mellitus	2.72e-05	0.000144	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—LPL—type 2 diabetes mellitus	2.72e-05	0.000144	CbGpPWpGaD
Tafluprost—PTGS2—Disease—APOA1—type 2 diabetes mellitus	2.69e-05	0.000143	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ADCY5—type 2 diabetes mellitus	2.66e-05	0.000141	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GPX1—type 2 diabetes mellitus	2.65e-05	0.000141	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CD36—type 2 diabetes mellitus	2.59e-05	0.000137	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.55e-05	0.000135	CbGpPWpGaD
Tafluprost—PTGS2—Disease—NOS2—type 2 diabetes mellitus	2.54e-05	0.000135	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—MTHFR—type 2 diabetes mellitus	2.45e-05	0.00013	CbGpPWpGaD
Tafluprost—PTGS2—Disease—IRS1—type 2 diabetes mellitus	2.43e-05	0.000129	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PPARA—type 2 diabetes mellitus	2.4e-05	0.000127	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—AGT—type 2 diabetes mellitus	2.33e-05	0.000123	CbGpPWpGaD
Tafluprost—PTGS2—Disease—INS—type 2 diabetes mellitus	2.33e-05	0.000123	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CALM1—type 2 diabetes mellitus	2.29e-05	0.000121	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—APOE—type 2 diabetes mellitus	2.28e-05	0.000121	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—APOA1—type 2 diabetes mellitus	2.25e-05	0.00012	CbGpPWpGaD
Tafluprost—PTGS2—Disease—AKT2—type 2 diabetes mellitus	2.25e-05	0.000119	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IL6—type 2 diabetes mellitus	2.18e-05	0.000116	CbGpPWpGaD
Tafluprost—PTGS2—Disease—SERPINE1—type 2 diabetes mellitus	2.14e-05	0.000113	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PIK3R1—type 2 diabetes mellitus	2.04e-05	0.000108	CbGpPWpGaD
Tafluprost—PTGS2—Disease—NOS3—type 2 diabetes mellitus	2.04e-05	0.000108	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.01e-05	0.000107	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PPARG—type 2 diabetes mellitus	1.99e-05	0.000105	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—INS—type 2 diabetes mellitus	1.95e-05	0.000103	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ALB—type 2 diabetes mellitus	1.79e-05	9.47e-05	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—NOS3—type 2 diabetes mellitus	1.71e-05	9.06e-05	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.71e-05	9.06e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—SRC—type 2 diabetes mellitus	1.51e-05	8e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—TGFB1—type 2 diabetes mellitus	1.35e-05	7.16e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—EGFR—type 2 diabetes mellitus	1.32e-05	7.02e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—IL6—type 2 diabetes mellitus	1.02e-05	5.39e-05	CbGpPWpGaD
Tafluprost—PTGS2—Disease—AKT1—type 2 diabetes mellitus	9.38e-06	4.97e-05	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—AKT1—type 2 diabetes mellitus	7.86e-06	4.17e-05	CbGpPWpGaD
